Piyasa güncellemeleri ve tahminleri

Finansal piyasa güncellemeleri, Merkez Bankalarının politika duyuruları, finansal göstergeler ve sektör üzerinde etkisi olabilecek diğer ilgili haberler de dahil olmak üzere ForExmart'tan en son ekonomik haberleri alın.

Yasal Uyarı:  ForexMart yatırım tavsiyesi sunmaz ve sağlanan analizler gelecekteki sonuçların vaadi olarak yorumlanmamalıdır.

Merck shares rise after news of COVID-19 medicine


Ekim, 01 2021
watermark Economic news

Shares of the pharmaceutical company Merck are gaining more than 8% at the end of the week after the company announced that it had developed an experimental drug that could significantly reduce the number of hospitalizations and deaths among people newly infected with coronavirus.


The company intends to request permission to use the drug in the United States and around the world in the near future. If approved, Merck tablets will be the first drug designed to treat COVID-19. And this is already a very big step forward in efforts to combat the global pandemic.


The first results presented by Merck and its partner Ridgeback Biotherapeutics showed that patients receiving the drug Molnupiravir had approximately ½ fewer hospitalizations and deaths compared to patients who received a placebo. The study involved 775 adults with mild to moderate coronavirus.



    






Geri Bildirim

ForexMart is authorized and regulated in various jurisdictions.

(Reg No.23071, IBC 2015) with a registered office at First Floor, SVG Teachers Co-operative Credit Union Limited Uptown Building, Corner of James and Middle Street, Kingstown, Saint Vincent and the Grenadines

Restricted Regions: the United States of America, North Korea, Sudan, Syria and some other regions.


© 2015-2025 Tradomart SV Ltd.
Top Top

show error

Unable to load the requested language file: language/turkish/cookies_lang.php

date: 2025-07-01 11:25:26 IP: 216.73.216.114